Immunopharmacological profile of HWA 486, a novel isoxazol derivative- II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A

International Journal of Immunopharmacology

Volumn 8, Issue 2, 1986, Pages 199-204

  Bartlett, Robert R ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ESCHERICHIA COLI ENDOTOXIN; LEFLUNOMIDE; PHYTOHEMAGGLUTININ; PREDNISOLONE;

ARTHRITIS; B LYMPHOCYTE; BLOOD AND HEMOPOIETIC SYSTEM; CHEMOLUMINESCENCE; DRUG EFFICACY; IMMUNOMODULATION; IN VITRO STUDY; JOINT; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMAL; ANTIBODY FORMATION; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; CYCLOPHOSPHAMIDE; CYCLOSPORINS; FEMALE; IMMUNE SYSTEM; ISOXAZOLES; LUMINESCENCE; LYMPHOCYTE ACTIVATION; MICE; MITOGENS; OXAZOLES; PREDNISOLONE; T-LYMPHOCYTES;

EID: 0022607220     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(86)90059-7     Document Type: Article

References (20)

1. Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat
2. Biological effects of cyclosporin A: a new antilymphocytic agent
3. Effects of the new anti-lymphocytic peptide cyclosporin A in animals
4. Cyclosporin-A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukin-1 and interleukin-2
5. Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function
6. Further improvements in the plaque technique for detecting single antibody forming cells
7. Effects of methylprednisolone on the in vitro induction and function of suppressor cells in man
8. Antibody interaction with antigen
9. Concavalin A-induced suppression cell activity: opposing effects of hydrocortisone
10. The effects of cyclosporins on the cell cycle of T-lymphoid cell lines
11. Suppression of rat adjuvant disease by cyclophosphamide pretreatment; evidence for an antibody mediated component in the pathogenesis of the disease
12. The use of a standardized adjuvant arthritis assay to differentiate between anti-inflammatory and immunosuppressive agents
13. Inhibition of the antigen activated T-cell response by methylprednisolone is caused by inhibition of interleukin-2 (II-2) production
14. Suppression of human cytotoxic lymphocytes by methylprednisolone
15. Die pharmakologische Beeinflussung des oxidatives Stoffwechsels von Alveolar makrophagen
16. Limiting dilution analysis of alloantigen-reactive T-lymphocytes — II. Effect of cortisone and cyclophosphamide on cytolytic T-lymphocyte precursor frequencies in the thymus
17. Cyclosporine: Immunology, toxicity and pharmacology in experimental animals
18. Cyclosporin: A mechanism of action
19. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant—II Evidence that the disease is a disseminated immunologic response to exogenous antigen
20. Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical, and immunologic parameters